Alan Morris

CV
h-index20
3papers
75citations
Novelty37%
AI Score25

3 Papers

10.1CVSep 7, 2020Code
Benchmarking off-the-shelf statistical shape modeling tools in clinical applications

Anupama Goparaju, Alexandre Bone, Nan Hu et al.

Statistical shape modeling (SSM) is widely used in biology and medicine as a new generation of morphometric approaches for the quantitative analysis of anatomical shapes. Technological advancements of in vivo imaging have led to the development of open-source computational tools that automate the modeling of anatomical shapes and their population-level variability. However, little work has been done on the evaluation and validation of such tools in clinical applications that rely on morphometric quantifications (e.g., implant design and lesion screening). Here, we systematically assess the outcome of widely used, state-of-the-art SSM tools, namely ShapeWorks, Deformetrica, and SPHARM-PDM. We use both quantitative and qualitative metrics to evaluate shape models from different tools. We propose validation frameworks for anatomical landmark/measurement inference and lesion screening. We also present a lesion screening method to objectively characterize subtle abnormal shape changes with respect to learned population-level statistics of controls. Results demonstrate that SSM tools display different levels of consistencies, where ShapeWorks and Deformetrica models are more consistent compared to models from SPHARM-PDM due to the groupwise approach of estimating surface correspondences. Furthermore, ShapeWorks and Deformetrica shape models are found to capture clinically relevant population-level variability compared to SPHARM-PDM models.

2.0CVDec 29, 2023
Particle-Based Shape Modeling for Arbitrary Regions-of-Interest

Hong Xu, Alan Morris, Shireen Y. Elhabian

Statistical Shape Modeling (SSM) is a quantitative method for analyzing morphological variations in anatomical structures. These analyses often necessitate building models on targeted anatomical regions of interest to focus on specific morphological features. We propose an extension to \particle-based shape modeling (PSM), a widely used SSM framework, to allow shape modeling to arbitrary regions of interest. Existing methods to define regions of interest are computationally expensive and have topological limitations. To address these shortcomings, we use mesh fields to define free-form constraints, which allow for delimiting arbitrary regions of interest on shape surfaces. Furthermore, we add a quadratic penalty method to the model optimization to enable computationally efficient enforcement of any combination of cutting-plane and free-form constraints. We demonstrate the effectiveness of this method on a challenging synthetic dataset and two medical datasets.

7.1LGSep 30, 2018
Deep Learning for End-to-End Atrial Fibrillation Recurrence Estimation

Riddhish Bhalodia, Anupama Goparaju, Tim Sodergren et al.

Left atrium shape has been shown to be an independent predictor of recurrence after atrial fibrillation (AF) ablation. Shape-based representation is imperative to such an estimation process, where correspondence-based representation offers the most flexibility and ease-of-computation for population-level shape statistics. Nonetheless, population-level shape representations in the form of image segmentation and correspondence models derived from cardiac MRI require significant human resources with sufficient anatomy-specific expertise. In this paper, we propose a machine learning approach that uses deep networks to estimate AF recurrence by predicting shape descriptors directly from MRI images, with NO image pre-processing involved. We also propose a novel data augmentation scheme to effectively train a deep network in a limited training data setting. We compare this new method of estimating shape descriptors from images with the state-of-the-art correspondence-based shape modeling that requires image segmentation and correspondence optimization. Results show that the proposed method and the current state-of-the-art produce statistically similar outcomes on AF recurrence, eliminating the need for expensive pre-processing pipelines and associated human labor.